| Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters M Feuerer, L Herrero, D Cipolletta, A Naaz, J Wong, A Nayer, J Lee, ... Nature medicine 15 (8), 930-939, 2009 | 2363 | 2009 |
| PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells D Cipolletta, M Feuerer, A Li, N Kamei, J Lee, SE Shoelson, C Benoist, ... Nature 486 (7404), 549-553, 2012 | 1207 | 2012 |
| Prospects for combining targeted and conventional cancer therapy with immunotherapy P Gotwals, S Cameron, D Cipolletta, V Cremasco, A Crystal, B Hewes, ... Nature Reviews Cancer 17 (5), 286-301, 2017 | 919 | 2017 |
| Antigen-and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice D Kolodin, N van Panhuys, C Li, AM Magnuson, D Cipolletta, CM Miller, ... Cell metabolism 21 (4), 543-557, 2015 | 357 | 2015 |
| Appearance and disappearance of the mRNA signature characteristic of Treg cells in visceral adipose tissue: Age, diet, and PPARγ effects D Cipolletta, P Cohen, BM Spiegelman, C Benoist, D Mathis Proceedings of the National Academy of Sciences 112 (2), 482-487, 2015 | 185 | 2015 |
| Tissular Tregs: a unique population of adipose-tissue-resident Foxp3+ CD4+ T cells that impacts organismal metabolism D Cipolletta, D Kolodin, C Benoist, D Mathis Seminars in immunology 23 (6), 431-437, 2011 | 150 | 2011 |
| Adipose tissue‐resident regulatory T cells: phenotypic specialization, functions and therapeutic potential D Cipolletta Immunology 142 (4), 517-525, 2014 | 135 | 2014 |
| An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes J Darce, D Rudra, L Li, J Nishio, D Cipolletta, AY Rudensky, D Mathis, ... Immunity 36 (5), 731-741, 2012 | 123 | 2012 |
| Fat Treg cells: a liaison between the immune and metabolic systems M Feuerer, L Herrero, D Cipolletta, A Naaz, J Wong, A Nayer, J Lee, ... Nature medicine 15 (8), 930, 2009 | 41 | 2009 |
| NF-κB blockade upregulates Bax, TSP-1, and TSP-2 expression in rat granulation tissue D De Stefano, G Nicolaus, MC Maiuri, D Cipolletta, L Galluzzi, MP Cinelli, ... Journal of molecular medicine 87, 481-492, 2009 | 25 | 2009 |
| Compositions and methods of use for augmented immune response and cancer therapy J Brogdon, D Cipolletta, G Dranoff, DA Knee, F Wang US Patent App. 15/517,872, 2017 | 8 | 2017 |
| VARIANT IgG FC POLYPEPTIDES AND USES THEREOF YL Chen, R Peckner, N Higginson-Scott, D Cipolletta, Y Zhou, KL Otipoby, ... US Patent App. 18/494,454, 2024 | | 2024 |
| IMPACTing autoimmunity through dual targeting of antigen presenting cells and T cells via inhibitory receptor agonism SJ Grebinoski, S Lutz, M Cianci, M Borah, A Stanlie, R Goydel, ... The Journal of Immunology 210 (1_Supplement), 146.03-146.03, 2023 | | 2023 |
| Identification and characterization of selective FcγRIIb binders and their potential of IMPACTing immune-mediated diseases S Lutz, M Cianci, SJ Grebinoski, M Borah, A Stanlie, R Goydel, ... The Journal of Immunology 210 (1_Supplement), 238.21-238.21, 2023 | | 2023 |
| Combined use of anti PD-1 and anti M-CSF antibodies in the treatment of cancer ML Fjaellskog, JS Cameron, Z Cao, D Cipolletta, K MacIsaac US Patent 11,001,628, 2021 | | 2021 |
| الاستخدام المشترك للاجسمام المضادة pd-1 ومضادات m-csf في علاج السرطان F Marie-Louise, C Daniela, C Zhu, M Kenzie, C John | | 2021 |
| Compositions and methods of use for augmented immune response and cancer therapy J Brogdon, D Cipolletta, G Dranoff, DA Knee, F Wang US Patent App. 16/845,030, 2021 | | 2021 |
| Compositions and methods of use for augmented immune response and cancer therapy J Brogdon, D Cipolletta, G Dranoff, DA Knee, F Wang US Patent 10,662,247, 2020 | | 2020 |
| Novel combination for use in the treatment of cancer J Cameron, Z Cao, D Cipolletta, ML Fjaellskog, K Macisaac | | 2019 |
| Composiciones y métodos usados para aumentar la respuesta inmune y en la terapia del cáncer D Glenn, AK Deborah, C Daniela, W Fei | | 2019 |
